Evoke Pharma, Inc. (NASDAQ:EVOK – Get Free Report) was the recipient of a significant drop in short interest in February. As of February 28th, there was short interest totalling 31,200 shares, a drop of 28.9% from the February 13th total of 43,900 shares. Based on an average daily volume of 18,400 shares, the days-to-cover ratio is presently 1.7 days. Currently, 2.2% of the shares of the stock are sold short.
Wall Street Analyst Weigh In
Separately, StockNews.com assumed coverage on shares of Evoke Pharma in a report on Wednesday, March 12th. They issued a “sell” rating for the company.
Institutional Inflows and Outflows
Evoke Pharma Trading Down 10.2 %
Shares of EVOK stock traded down $0.39 on Monday, reaching $3.43. The company’s stock had a trading volume of 48,202 shares, compared to its average volume of 119,644. The stock’s fifty day simple moving average is $4.53 and its 200-day simple moving average is $4.71. Evoke Pharma has a 1 year low of $3.33 and a 1 year high of $12.32. The company has a market capitalization of $5.10 million, a price-to-earnings ratio of -0.31 and a beta of 0.12.
Evoke Pharma (NASDAQ:EVOK – Get Free Report) last posted its quarterly earnings data on Thursday, March 13th. The specialty pharmaceutical company reported ($0.49) EPS for the quarter, missing the consensus estimate of ($0.25) by ($0.24). The firm had revenue of $3.31 million for the quarter, compared to analysts’ expectations of $3.08 million. Evoke Pharma had a negative return on equity of 308.49% and a negative net margin of 71.32%.
About Evoke Pharma
Evoke Pharma, Inc, a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It offers Gimoti, a metoclopramide nasal spray to treat symptoms associated with acute and recurrent diabetic gastroparesis in adults.
Featured Articles
- Five stocks we like better than Evoke Pharma
- How to Find Undervalued Stocks
- Can TikTok Stock Picks Really Make You Rich?
- Comparing and Trading High PE Ratio Stocks
- The “Quality” Rotation: Back to Basics Investing
- What is a support level?
- Occidental Petroleum: 4 Reasons to Love These Prices
Receive News & Ratings for Evoke Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evoke Pharma and related companies with MarketBeat.com's FREE daily email newsletter.